Federal Appeals Court Overturns $223 Million Jury Award in Johnson & Johnson Talc-Related Cancer Case

The federal appeals court has overturned a $223 million jury award in a case where New Jersey residents claimed they developed cancer from using Johnson & Johnson’s talc-based products, according to reports and a recent ruling. The appellate division of the Superior Court of New Jersey stated that the scientific testimony linking J&J’s products to the cancers was improper and should not have been presented to the jurors. The panel explained that the experts for the plaintiffs failed to provide sufficient explanations for the facts or methods supporting their claims.

Erik Haas, Worldwide Vice President of Litigation for Johnson & Johnson, expressed satisfaction with the decision, stating that it rejects the “junk science” presented by experts paid by the mass tort asbestos bar. He emphasized that this ruling is the third in three years to overturn large verdicts obtained through misleading juries with unscientific opinions and baseless liability theories. Haas added that while the company sympathizes with cancer sufferers, it is crucial to rely on facts when assessing the situation.

As a result of the ruling, a new trial has been ordered. Johnson & Johnson maintains a dedicated website showcasing their position and providing information on the science supporting the safety of their products. The full decision is available for review in the October 3 ruling.

In conclusion, a federal appeals court has thrown out a $223 million jury award in a case involving New Jersey residents who alleged that Johnson & Johnson’s talc-based products caused their cancer. The court ruled that the improper scientific testimony linking the products to the cancers should not have been presented to the jurors. Johnson & Johnson welcomed the decision and highlighted the rejection of what they consider to be “junk science.” A new trial has been ordered, and Johnson & Johnson continues to assert the safety of their products on their dedicated website.